Commonwealth Equity Services’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $445K | Sell |
8,602
-1,774
| -17% | -$90.3K | ﹤0.01% | 3311 |
|
|
2025
Q4 | $516K | Buy |
10,376
+1,910
| +23% | +$92.9K | ﹤0.01% | 3159 |
|
|
2025
Q3 | $405K | Sell |
8,466
-1,229
| -13% | -$49.5K | ﹤0.01% | 3361 |
|
|
2025
Q2 | $306K | Buy |
9,695
+109
| +1% | +$3.49K | ﹤0.01% | 3560 |
|
|
2025
Q1 | $314K | Sell |
9,586
-210
| -2% | -$7.44K | ﹤0.01% | 3454 |
|
|
2024
Q4 | $354K | Sell |
9,796
-454
| -4% | -$16K | ﹤0.01% | 3266 |
|
|
2024
Q3 | $320K | Buy |
10,250
+55
| +0.5% | +$1.72K | ﹤0.01% | 3297 |
|
|
2024
Q2 | $273K | Buy |
10,195
+350
| +4% | +$10.1K | ﹤0.01% | 3377 |
|
|
2024
Q1 | $336K | Sell |
9,845
-185
| -2% | -$5.51K | ﹤0.01% | 3171 |
|
|
2023
Q4 | $290K | Buy |
10,030
+382
| +4% | +$10.1K | ﹤0.01% | 3212 |
|
|
2023
Q3 | $266K | Buy |
9,648
+197
| +2% | +$6K | ﹤0.01% | 3135 |
|
|
2023
Q2 | $284K | Buy |
9,451
+550
| +6% | +$19.2K | ﹤0.01% | 3101 |
|
|
2023
Q1 | $322 | Buy |
8,901
+200
| +2% | +$7.69K | ﹤0.01% | 2915 |
|
|
2022
Q4 | $310K | Sell |
8,701
-1,518
| -15% | -$52.8K | ﹤0.01% | 2842 |
|
|
2022
Q3 | $345K | Sell |
10,219
-385
| -4% | -$12.5K | ﹤0.01% | 2709 |
|
|
2022
Q2 | $306K | Buy |
10,604
+181
| +2% | +$5.18K | ﹤0.01% | 2829 |
|
|
2022
Q1 | $336K | Sell |
10,423
-286
| -3% | -$8.77K | ﹤0.01% | 2877 |
|
|
2021
Q4 | $312K | Sell |
10,709
-671
| -6% | -$20.4K | ﹤0.01% | 2942 |
|
|
2021
Q3 | $303K | Buy |
11,380
+1,440
| +14% | +$38.7K | ﹤0.01% | 2919 |
|
|
2021
Q2 | $306K | Buy |
9,940
+362
| +4% | +$11.1K | ﹤0.01% | 2879 |
|
|
2021
Q1 | $250K | Hold |
9,578
| – | – | ﹤0.01% | 2942 |
|
|
2020
Q4 | $240K | Buy |
+9,578
| New | +$206K | ﹤0.01% | 2771 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
